First-in-class antibody development program to treat major autoimmune diseases
Newly discovered antibodies promise significant improvement over current therapies
Newly discovered antibodies promise significant improvement over current therapies
Thermo Fisher Scientific Orbitrap GC-MS technology to be integrated into Breath Biopsy to support identification of novel biomarkers for early disease detection
Hitachi and the Centre Leon Berard Cancer Center to launch research into diagnosis and treatment
Envigo enters CRISPR gene-edited research model field with the addition of Horizon’s business
Zelluna Immunotherapy presented data on its lead compound ZI-H04 at the Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
The Sentosa® SQ HIV-1 Genotyping Assay is the first FDA De Novo-designated NGS assay for detecting HIV-1 drug resistance mutations
Promega enters global collaboration with Merck to develop Microsatellite Instability (MSI) companion diagnostic for use with KEYTRUDA®
Technology brings University scientists unparalleled potential for chemical, biological and human disease research
MOBILion joins with investigators at the University of Georgia’s Complex Carbohydrate Research Center
Lead allosteric PLK1 inhibitor to progress through preclinical and IND enabling studies
Advanced flow cytometry systems now sold in over 20 countries across five continents with new offices opened in Europe and Japan
Global Biolife Inc. to present at the American Society for microbiology's biothreats conference
Rigaku to present portfolio of handheld Raman analyzers at IACP annual conference and exposition
Collaboration to offer high-performance solutions for industrial and material applications
Engineered signaling pathways could offer a new way to build synthetic biology circuits
Low-cost, flexible and dependable automation possibilities open up for any research group
Thermo Fisher Scientific's forum focuses on strategies to expedite biotherapeutic development and commercialization